Precigen Competitors and Similar CompaniesClear all
Precigen's competitors and similar companies include Ethris and ProQR Therapeutics.
 Precigen Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases. |  Ethris Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia. |  ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases. | |
Founding Date | Founding Date 1998 | Founding Date 2009 | Founding Date 2012 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Germantown, US HQ Gent, BE Sioux Center, US | Locations Planegg, DE HQ | Locations Leiden, NL HQ Cambridge, US |
Employees | Employees 601 | Employees 504% decrease | Employees 166 |
Valuation ($) | Valuation ($) 246.6 m | Valuation ($) N/A | Valuation ($) 281.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) $9.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €15.9m (FY, 2025) |
Net income | Net income ($250.6m) (FY, 2025) | Net income N/A | Net income (€42.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 379m | Total funding raised N/A | Total funding raised $ 57.8m |
For sources of this data, please see the company profile
View Company Profiles
Ethris
HQ
Planegg, DE
Employees
50↓ 4% decrease
Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia.
View companyProQR Therapeutics
HQ
Leiden, NL
Employees
166
ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
View company